Pentetic Acid

Pentetic Acid

SCHEMBL9440802

Nc1ccc(N)cc1.O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.65
KDM4E B2RXH2 1/20 0.65
LMNA P02545 1/20 0.65
CHRM2 P08172 1/20 0.65
ADRA2A P08913 1/20 0.65
ALOX15 P16050 1/20 0.65
TSHR P16473 1/20 0.65
DRD1 P21728 1/20 0.65
SLC6A2 P23975 1/20 0.65
SLC6A4 P31645 1/20 0.65
CYP2C19 P33261 1/20 0.65
ADRA1A P35348 1/20 0.65
DRD3 P35462 1/20 0.65
BLM P54132 1/20 0.65
PMP22 Q01453 1/20 0.65
SLC6A3 Q01959 1/20 0.65
HRH3 Q9Y5N1 1/20 0.65
EYA2 O00167 1/20 0.61
APP P05067 1/20 0.61
ACE P12821 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9878685 0.89 TDP1 (0.52) TDP1KDM4ELMNACHRM2ADRA2A
SCHEMBL14357548 0.85 CA1 (0.48) TDP1KDM4ELMNACHRM2ADRA2A
SCHEMBL19663826 0.85 CA1 (0.70) CA1CA2CA4CA12CA9
Pentetic Acid SCHEMBL10361749 0.83 TDP1 (0.60) TDP1KDM4ELMNACHRM2ADRA2A
Pentetic Acid SCHEMBL9440537 0.81 TDP1 (0.88) TDP1KDM4ELMNACHRM2ADRA2A
SCHEMBL8425241 0.81 MAPT (0.48) TDP1KDM4ELMNACHRM2ADRA2A
Pentetic Acid SCHEMBL17138 0.81 TDP1 (1.00) TDP1KDM4ELMNACHRM2ADRA2A
SCHEMBL137691 0.81 TDP1 (1.00) TDP1KDM4ELMNACHRM2ADRA2A
Pentetic Acid SCHEMBL2468143 0.81 TDP1 (1.00) TDP1KDM4ELMNACHRM2ADRA2A
SCHEMBL8866720 0.81 TDP1 (1.00) TDP1KDM4ELMNACHRM2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0353295-B1 NOVEL AND IMPROVED ANTIBODIES FOR SITE SPECIFIC ATTACHMENT OF COMPOUNDS CYTOGEN CORP (US) 1994-04-06 EP claimed
EP-0173629-B1 ANTIBODY-METAL ION COMPLEXES CYTOGEN CORPORATION (US) 1992-06-10 EP claimed
EP-0382796-A4 METHOD FOR THE PREPARATION OF ANTIBODY-FRAGMENT CONJUGATES 1991-08-28 EP claimed
EP-0382796-A1 METHOD FOR THE PREPARATION OF ANTIBODY-FRAGMENT CONJUGATES CYTOGEN CORPORATION (US) 1990-08-22 EP claimed
EP-0353295-A4 NOVEL AND IMPROVED ANTIBODIES FOR SITE SPECIFIC ATTACHMENT OF COMPOUNDS. CYTOGEN CORP (US) 1990-06-26 EP claimed
US-4937183-A Therapy, diagnostis immunology CYTOGEN CORPORATION (US) 1990-06-26 US claimed
EP-0353295-A1 NOVEL AND IMPROVED ANTIBODIES FOR SITE SPECIFIC ATTACHMENT OF COMPOUNDS. CYTOGEN CORP (US) 1990-02-07 EP claimed
WO-1989007269-A1 METHOD FOR THE PREPARATION OF ANTIBODY-FRAGMENT CONJUGATES CYTOGEN CORPORATION (US) 1989-08-10 WO claimed
WO-1989007114-A1 NOVEL AND IMPROVED ANTIBODIES FOR SITE SPECIFIC ATTACHMENT OF COMPOUNDS CYTOGEN CORPORATION (US) 1989-08-10 WO claimed
US-4741900-A Antibody-metal ion complexes CYTOGEN CORPORATION (US) 1988-05-03 US claimed
WO-1986001410-A1 ANTIBODY-METAL ION COMPLEXES CYTOGEN CORPORATION (US) 1986-03-13 WO claimed
EP-0173629-A1 Antibody-metal ion complexes CYTOGEN CORPORATION (US) 1986-03-05 EP claimed
EP-0173629-B1 ANTIBODY-METAL ION COMPLEXES CYTOGEN CORPORATION (US) 1992-06-10 EP disclosed
US-4741900-A Antibody-metal ion complexes CYTOGEN CORPORATION (US) 1988-05-03 US disclosed
EP-0257940-A2 A method of analyzing high molecular weight dispersants in motor oils The Lubrizol Corporation (US) 1988-03-02 EP disclosed
EP-0119675-B1 HYDROCARBYL-SUBSTITUTED MONO AND BIS SUCCINIMIDE HAVING POLYAMINE CHAIN LINKED HYDROXYACYL RADICALS AND MINERAL OIL COMPOSITIONS CONTAINING SAME TEXACO DEVELOPMENT CORPORATION (US) 1986-10-29 EP disclosed
WO-1986001410-A1 ANTIBODY-METAL ION COMPLEXES CYTOGEN CORPORATION (US) 1986-03-13 WO disclosed
EP-0173629-A1 Antibody-metal ion complexes CYTOGEN CORPORATION (US) 1986-03-05 EP disclosed